PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Sumatriptan - Migraine (acute)
PAD Profile : Sumatriptan - Migraine (acute) Important
Keywords :
migraine treatment, acute migraine, triptans
Brand Names Include :
Imigran
Important Information :
Prescribe generically.
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
- Naratriptan hydrochloride
- Zolmitriptan
- Frovatriptan
- Almotriptan
- Eletriptan
- Rizatriptan
- Melatonin
- Rimegepant
- Analgesics with anti-emetics
Other Indications
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
03 May 2017
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
GENERIC Sumatriptan has been considered by the PCN and has been assigned a GREEN traffic light status.
NOTE - the branded product, Imigran, was considered BLACK at the PCN in May 2017.
02 March 2016
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
UPDATED: The PCN recommends that sumatriptan, zolmitriptan, rizatriptan and naratriptan should be considered as first line triptans where clinically appropriate and should be prescribed generically.
Associated BNF Codes
04. Central Nervous System
04.07.04. Antimigraine drugs